Mikkel Jessing

This inventor holds 33 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 14 EPO patents. Top assignees: H. Lundbeck A/s, Mindimmune Therapeutics, Inc.. Active years: 2015-2024.

USPTO Granted Patents = 33 (Patent Applications = 7)

% Patents Active = 69.7

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 14 (Patent Applications = 19)

Average Co-Inventor Count = 6.5

ph-index = 6

Forward Citations = 116(Granted Patents)

Location History:

København NV, DK (2015)
København, DK (2017)
København Ø, DK (2016 - 2018)
København ç, DK (2019)
Fredriksberg, DK (2020)
Frederiksberg, DK (2018 - 2023)
Valby, DK (2018 - 2024)

Company Filing History:

Mindimmune Therapeutics, Inc.

patents

Years Active: 2015-2024

Loading Chart...

Areas of Expertise:

LRRK2 Inhibitors

PDE1 Inhibitors

1H-Pyrazolo[4,3-B]Pyridines

Imidazopyrazinones

Combination Treatments

Macrocycles

Triazolopyrazinones

Cyclic Amines

Benzamide-Containing Compounds

Leucine-Rich Repeat Kinase 2

Pyrazolo[3,4-B]Pyridines

Epilepsy Treatment

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11993612 - LRRK2 inhibitors (2024-05-28),

2. 11958865 - Leucine-rich repeat kinase 2 (LRRK2) inhibitors (2024-04-16),

3. 11851425 - Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines (2023-12-26),

4. 11780851 - LRRK2 inhibitors (2023-10-10),

5. 11634416 - Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines (2023-04-25),

6. 11535611 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors (2022-12-27),

7. 11491140 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2022-11-08),

8. 11472810 - Imidazopyrazinones as PDE1 inhibitors (2022-10-18),

9. 11104680 - 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors (2021-08-31),

10. 11026924 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),

11. 11026923 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),

12. 10912773 - Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors (2021-02-09),

13. 10905688 - Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors (2021-02-02),

14. 10858362 - Imidazopyrazinones as PDE1 inhibitors (2020-12-08),

15. 10806718 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2020-10-20),

Title: The Innovative Mind of Mikkel Jessing

Introduction: Mikkel Jessing, a talented inventor hailing from Frederiksberg, Denmark, is known for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Mikkel Jessing has recently been granted several patents for his cutting-edge inventions in the fields of renewable energy and sustainable technology, showcasing his commitment to creating a greener future for generations to come.

Career Highlights: With a career spanning over two decades, Mikkel Jessing has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has revolutionized industries such as clean energy, smart infrastructure, and digital healthcare.

Collaborations: Throughout his career, Mikkel Jessing has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking technologies.

Conclusion: In conclusion, Mikkel Jessing's passion for innovation, coupled with his technical expertise and collaborative spirit, has cemented his reputation as a pioneering inventor in the global tech landscape. His relentless pursuit of excellence and commitment to creating a more sustainable world continue to inspire future generations of inventors and innovators.